PFG Advisors Sells 145 Shares of iShares Biotechnology ETF (NASDAQ:IBB)

PFG Advisors decreased its holdings in iShares Biotechnology ETF (NASDAQ:IBB) by 3.2% in the fourth quarter, Holdings Channel.com reports. The institutional investor owned 4,401 shares of the financial services provider’s stock after selling 145 shares during the period. PFG Advisors’ holdings in iShares Biotechnology ETF were worth $582,000 as of its most recent filing with the SEC.

A number of other hedge funds have also bought and sold shares of IBB. BNP Paribas Financial Markets raised its position in iShares Biotechnology ETF by 29.3% in the 3rd quarter. BNP Paribas Financial Markets now owns 2,380,229 shares of the financial services provider’s stock worth $346,561,000 after buying an additional 538,899 shares during the last quarter. Raymond James Financial Inc. bought a new position in shares of iShares Biotechnology ETF during the 4th quarter valued at approximately $55,010,000. Healthcare of Ontario Pension Plan Trust Fund grew its stake in shares of iShares Biotechnology ETF by 32.9% during the 3rd quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 663,000 shares of the financial services provider’s stock valued at $96,533,000 after acquiring an additional 164,000 shares during the period. Aprio Wealth Management LLC bought a new position in shares of iShares Biotechnology ETF during the 4th quarter valued at approximately $18,476,000. Finally, Generali Investments CEE investicni spolecnost a.s. bought a new position in iShares Biotechnology ETF in the 4th quarter worth approximately $11,370,000. Hedge funds and other institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Price Performance

IBB stock opened at $134.19 on Friday. iShares Biotechnology ETF has a 1-year low of $123.60 and a 1-year high of $150.57. The company has a market capitalization of $6.34 billion, a price-to-earnings ratio of 24.52 and a beta of 0.84. The business has a 50 day simple moving average of $136.25 and a two-hundred day simple moving average of $139.96.

iShares Biotechnology ETF Cuts Dividend

The firm also recently declared a dividend, which was paid on Friday, December 20th. Shareholders of record on Tuesday, December 17th were paid a $0.0624 dividend. The ex-dividend date was Tuesday, December 17th.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.